Name: Global Personalized Medicine Market Insights and Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.7 (136 reviews)

Global Personalized Medicine Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

The comprehensive research report on the Personalized Medicine Market influences iterative and comprehensive research methodology to offer insights of the existing market scenario over the forecast timeframe. The report also delivers in-depth details about the growth and development trends that will have a major impact on the behavior of the Personalized Medicine market in the approaching years. Furthermore, the report touches upon other key pointers such as the regional aspects and policies overriding the industry. Apart from this, the study highlights the COVID-19 pandemic’s effect on the revenue share and yearly growth rate of the market.

Data provided by Extent Research. Source: https://www.extentresearch.com/personalized-medicine-market

The Personalized Medicine market report has comprehensively provided information regarding the driving forces that have a huge impact on the market size. In addition, the dynamics of the industry are defined by studying the current and future trends of this industry vertical. Along with the competitive terrain even the regional landscape of the Personalized Medicine market is provided. The vast research can be clearly seen through the market analysis that provides data associated with advantages and disadvantages of the products developed by the manufacturers Abbott Laboratories, Agilent Technologies, Amgen, Astellas Pharma, Astrazeneca, Bayer AG, Celgene Corporation, Glaxosmithkline Plc, Illumina, Johnson & Johnson, Laboratory Corporation, Merck, Novartis AG, Roche Holding AG, Siemens AG, Takeda Pharmaceutical Company Limited, . Additionally, the entire evolution of the market dynamics along with the supply and demand chain of the product is presented in the research report.

Segmentation of the Global Personalized Medicine Market:

By Product type

Personalized Medicine Diagnostics, Personalized Medical Care, Personalized Medicine Therapeutics, Personalized Nutrition and Wellness,

by Application

Oncology, Central Nervous System (CNS), Immunology, Respiratory, Other Applications,

Additional takeaways from the Personalized Medicine market report:

Product spectrum elaboration
Volume and revenue share forecasts
Growth rate, market share, & production framework detailing over the forecast timeline

Highlights points of Personalized Medicine market:

Personalized Medicine market share by key players
Global growth drivers
Market size based on segmentation
Company profiles
Personalized Medicine market price and sales channel analysis
Personalized Medicine market forecast

Major questions answered in the report:

Which are the factors propelling the Personalized Medicine market?
What would be the growth rate of the Personalized Medicine market in forecast period?
What is the price analysis of the key players of the Personalized Medicine market?
What are the market opportunities & challenges faced by the key players?

Report Scope and Market Segmentation

ATTRIBUTES	Global Personalized Medicine Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Personalized Medicine Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Personalized Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Personalized Medicine Diagnostics
        1.2.3 Personalized Medical Care
        1.2.4 Personalized Medicine Therapeutics
        1.2.5 Personalized Nutrition and Wellness
    1.3 Market by Application
        1.3.1 Global Personalized Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Oncology
        1.3.3 Central Nervous System (CNS)
        1.3.4 Immunology
        1.3.5 Respiratory
        1.3.6 Other Applications
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Personalized Medicine Market Perspective (2017-2035)
    2.2 Personalized Medicine Growth Trends by Region
        2.2.1 Personalized Medicine Market Size by Region: 2017 VS 2021 VS 2035
        2.2.2 Personalized Medicine Historic Market Size by Region (2017-2022)
        2.2.3 Personalized Medicine Forecasted Market Size by Region (2023-2035)
    2.3 Personalized Medicine Market Dynamics
        2.3.1 Personalized Medicine Industry Trends
        2.3.2 Personalized Medicine Market Drivers
        2.3.3 Personalized Medicine Market Challenges
        2.3.4 Personalized Medicine Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Personalized Medicine Players by Revenue
        3.1.1 Global Top Personalized Medicine Players by Revenue (2017-2022)
        3.1.2 Global Personalized Medicine Revenue Market Share by Players (2017-2022)
    3.2 Global Personalized Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Personalized Medicine Revenue
    3.4 Global Personalized Medicine Market Concentration Ratio
        3.4.1 Global Personalized Medicine Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine Revenue in 2021
    3.5 Personalized Medicine Key Players Head office and Area Served
    3.6 Key Players Personalized Medicine Product Solution and Service
    3.7 Date of Enter into Personalized Medicine Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicine Breakdown Data by Type
    4.1 Global Personalized Medicine Historic Market Size by Type (2017-2022)
    4.2 Global Personalized Medicine Forecasted Market Size by Type (2023-2035)
5 Personalized Medicine Breakdown Data by Application
    5.1 Global Personalized Medicine Historic Market Size by Application (2017-2022)
    5.2 Global Personalized Medicine Forecasted Market Size by Application (2023-2035)
6 North America
    6.1 North America Personalized Medicine Market Size (2017-2035)
    6.2 North America Personalized Medicine Market Size by Type
        6.2.1 North America Personalized Medicine Market Size by Type (2017-2022)
        6.2.2 North America Personalized Medicine Market Size by Type (2023-2035)
        6.2.3 North America Personalized Medicine Market Share by Type (2017-2035)
    6.3 North America Personalized Medicine Market Size by Application
        6.3.1 North America Personalized Medicine Market Size by Application (2017-2022)
        6.3.2 North America Personalized Medicine Market Size by Application (2023-2035)
        6.3.3 North America Personalized Medicine Market Share by Application (2017-2035)
    6.4 North America Personalized Medicine Market Size by Country
        6.4.1 North America Personalized Medicine Market Size by Country (2017-2022)
        6.4.2 North America Personalized Medicine Market Size by Country (2023-2035)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Personalized Medicine Market Size (2017-2035)
    7.2 Europe Personalized Medicine Market Size by Type
        7.2.1 Europe Personalized Medicine Market Size by Type (2017-2022)
        7.2.2 Europe Personalized Medicine Market Size by Type (2023-2035)
        7.2.3 Europe Personalized Medicine Market Share by Type (2017-2035)
    7.3 Europe Personalized Medicine Market Size by Application
        7.3.1 Europe Personalized Medicine Market Size by Application (2017-2022)
        7.3.2 Europe Personalized Medicine Market Size by Application (2023-2035)
        7.3.3 Europe Personalized Medicine Market Share by Application (2017-2035)
    7.4 Europe Personalized Medicine Market Size by Country
        7.4.1 Europe Personalized Medicine Market Size by Country (2017-2022)
        7.4.2 Europe Personalized Medicine Market Size by Country (2023-2035)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Personalized Medicine Market Size (2017-2035)
    8.2 Asia-Pacific Personalized Medicine Market Size by Type
        8.2.1 Asia-Pacific Personalized Medicine Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Personalized Medicine Market Size by Type (2023-2035)
        8.2.3 Asia-Pacific Personalized Medicine Market Share by Type (2017-2035)
    8.3 Asia-Pacific Personalized Medicine Market Size by Application
        8.3.1 Asia-Pacific Personalized Medicine Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Personalized Medicine Market Size by Application (2023-2035)
        8.3.3 Asia-Pacific Personalized Medicine Market Share by Application (2017-2035)
    8.4 Asia-Pacific Personalized Medicine Market Size by Region
        8.4.1 Asia-Pacific Personalized Medicine Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Personalized Medicine Market Size by Region (2023-2035)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Personalized Medicine Market Size (2017-2035)
    9.2 Latin America Personalized Medicine Market Size by Type
        9.2.1 Latin America Personalized Medicine Market Size by Type (2017-2022)
        9.2.2 Latin America Personalized Medicine Market Size by Type (2023-2035)
        9.2.3 Latin America Personalized Medicine Market Share by Type (2017-2035)
    9.3 Latin America Personalized Medicine Market Size by Application
        9.3.1 Latin America Personalized Medicine Market Size by Application (2017-2022)
        9.3.2 Latin America Personalized Medicine Market Size by Application (2023-2035)
        9.3.3 Latin America Personalized Medicine Market Share by Application (2017-2035)
    9.4 Latin America Personalized Medicine Market Size by Country
        9.4.1 Latin America Personalized Medicine Market Size by Country (2017-2022)
        9.4.2 Latin America Personalized Medicine Market Size by Country (2023-2035)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Personalized Medicine Market Size (2017-2035)
    10.2 Middle East & Africa Personalized Medicine Market Size by Type
        10.2.1 Middle East & Africa Personalized Medicine Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Personalized Medicine Market Size by Type (2023-2035)
        10.2.3 Middle East & Africa Personalized Medicine Market Share by Type (2017-2035)
    10.3 Middle East & Africa Personalized Medicine Market Size by Application
        10.3.1 Middle East & Africa Personalized Medicine Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Personalized Medicine Market Size by Application (2023-2035)
        10.3.3 Middle East & Africa Personalized Medicine Market Share by Application (2017-2035)
    10.4 Middle East & Africa Personalized Medicine Market Size by Country
        10.4.1 Middle East & Africa Personalized Medicine Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Personalized Medicine Market Size by Country (2023-2035)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Details
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Personalized Medicine Introduction
        11.1.4 Abbott Laboratories Revenue in Personalized Medicine Business (2017-2022)
        11.1.5 Abbott Laboratories Recent Developments
    11.2 Agilent Technologies
        11.2.1 Agilent Technologies Company Details
        11.2.2 Agilent Technologies Business Overview
        11.2.3 Agilent Technologies Personalized Medicine Introduction
        11.2.4 Agilent Technologies Revenue in Personalized Medicine Business (2017-2022)
        11.2.5 Agilent Technologies Recent Developments
    11.3 Amgen
        11.3.1 Amgen Company Details
        11.3.2 Amgen Business Overview
        11.3.3 Amgen Personalized Medicine Introduction
        11.3.4 Amgen Revenue in Personalized Medicine Business (2017-2022)
        11.3.5 Amgen Recent Developments
    11.4 Astellas Pharma
        11.4.1 Astellas Pharma Company Details
        11.4.2 Astellas Pharma Business Overview
        11.4.3 Astellas Pharma Personalized Medicine Introduction
        11.4.4 Astellas Pharma Revenue in Personalized Medicine Business (2017-2022)
        11.4.5 Astellas Pharma Recent Developments
    11.5 Astrazeneca
        11.5.1 Astrazeneca Company Details
        11.5.2 Astrazeneca Business Overview
        11.5.3 Astrazeneca Personalized Medicine Introduction
        11.5.4 Astrazeneca Revenue in Personalized Medicine Business (2017-2022)
        11.5.5 Astrazeneca Recent Developments
    11.6 Bayer AG
        11.6.1 Bayer AG Company Details
        11.6.2 Bayer AG Business Overview
        11.6.3 Bayer AG Personalized Medicine Introduction
        11.6.4 Bayer AG Revenue in Personalized Medicine Business (2017-2022)
        11.6.5 Bayer AG Recent Developments
    11.7 Celgene Corporation
        11.7.1 Celgene Corporation Company Details
        11.7.2 Celgene Corporation Business Overview
        11.7.3 Celgene Corporation Personalized Medicine Introduction
        11.7.4 Celgene Corporation Revenue in Personalized Medicine Business (2017-2022)
        11.7.5 Celgene Corporation Recent Developments
    11.8 Glaxosmithkline Plc
        11.8.1 Glaxosmithkline Plc Company Details
        11.8.2 Glaxosmithkline Plc Business Overview
        11.8.3 Glaxosmithkline Plc Personalized Medicine Introduction
        11.8.4 Glaxosmithkline Plc Revenue in Personalized Medicine Business (2017-2022)
        11.8.5 Glaxosmithkline Plc Recent Developments
    11.9 Illumina
        11.9.1 Illumina Company Details
        11.9.2 Illumina Business Overview
        11.9.3 Illumina Personalized Medicine Introduction
        11.9.4 Illumina Revenue in Personalized Medicine Business (2017-2022)
        11.9.5 Illumina Recent Developments
    11.10 Johnson & Johnson
        11.10.1 Johnson & Johnson Company Details
        11.10.2 Johnson & Johnson Business Overview
        11.10.3 Johnson & Johnson Personalized Medicine Introduction
        11.10.4 Johnson & Johnson Revenue in Personalized Medicine Business (2017-2022)
        11.10.5 Johnson & Johnson Recent Developments
    11.11 Laboratory Corporation
        11.11.1 Laboratory Corporation Company Details
        11.11.2 Laboratory Corporation Business Overview
        11.11.3 Laboratory Corporation Personalized Medicine Introduction
        11.11.4 Laboratory Corporation Revenue in Personalized Medicine Business (2017-2022)
        11.11.5 Laboratory Corporation Recent Developments
    11.12 Merck
        11.12.1 Merck Company Details
        11.12.2 Merck Business Overview
        11.12.3 Merck Personalized Medicine Introduction
        11.12.4 Merck Revenue in Personalized Medicine Business (2017-2022)
        11.12.5 Merck Recent Developments
    11.13 Novartis AG
        11.13.1 Novartis AG Company Details
        11.13.2 Novartis AG Business Overview
        11.13.3 Novartis AG Personalized Medicine Introduction
        11.13.4 Novartis AG Revenue in Personalized Medicine Business (2017-2022)
        11.13.5 Novartis AG Recent Developments
    11.14 Roche Holding AG
        11.14.1 Roche Holding AG Company Details
        11.14.2 Roche Holding AG Business Overview
        11.14.3 Roche Holding AG Personalized Medicine Introduction
        11.14.4 Roche Holding AG Revenue in Personalized Medicine Business (2017-2022)
        11.14.5 Roche Holding AG Recent Developments
    11.15 Siemens AG
        11.15.1 Siemens AG Company Details
        11.15.2 Siemens AG Business Overview
        11.15.3 Siemens AG Personalized Medicine Introduction
        11.15.4 Siemens AG Revenue in Personalized Medicine Business (2017-2022)
        11.15.5 Siemens AG Recent Developments
    11.16 Takeda Pharmaceutical Company Limited
        11.16.1 Takeda Pharmaceutical Company Limited Company Details
        11.16.2 Takeda Pharmaceutical Company Limited Business Overview
        11.16.3 Takeda Pharmaceutical Company Limited Personalized Medicine Introduction
        11.16.4 Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2017-2022)
        11.16.5 Takeda Pharmaceutical Company Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Personalized Medicine Market